The latest policy and advocacy updates related to the field of clinical and translational science.
Congress and the administration remain focused on addressing the ongoing COVID-19 pandemic in a meaningful way. Congress has passed three COVID-19 legislative packages including a combination of emergency supplemental appropriations for medical research and public health programs, access related health policy changes, and economic stimulus measures. As the administration implements enacted legislation, Congress is debating a fourth response package and laying the groundwork for further legislation. At this time, the fourth (narrow) COVID-19 response package consists of additional public health funding and further economic stimulus measures, specifically:
Congress also continues to work on annual legislative priorities, most notably the (Fiscal Year) FY 2021 appropriations process. However, with the Capitol closed, legislators have begun exploring alternative options for hearings, markups, and floor votes. Congress remains committed to advancing the FY 2021 spending bills, but the timeline and specific process has become less clear.